Enzalutamide in patients with non-metastatic castration-resistant prostate cancer after combined androgen blockade for recurrence following radical treatment in Japan (Japanese research for patients with non-metastatic castration-resistant prostate cancer-enzalutamide: JCASTRE-zero)—a prospective single-arm interventional study

被引：0
|
作者：
Mikio Sugimoto
Takuma Kato
Yoichiro Tohi
Yosuke Shimizu
Ryuji Matsumoto
Takahiro Inoue
Yutaka Takezawa
Kimihiko Masui
Hiroshi Sasaki
Hiromi Hirama
Shiro Saito
Shin Egawa
Toshiyuki Kamoto
Satoshi Teramukai
Shinsuke Kojima
Takashi Kikuchi
Yoshiyuki Kakehi
机构：
[1] Kagawa University,Department of Urology, Faculty of Medicine
[2] Kobe City Nishi-Kobe Medical Center,Department of Urology
[3] Hokkaido University Graduate School of Medicine,Department of Urology
[4] Kyoto University,Department of Urology, Graduate School of Medicine
[5] Isesaki Municipal Hospital,Department of Urology
[6] Otsu City Hospital,Department of Urology
[7] Jikei University School of Medicine,Department of Urology
[8] National Hospital Organization Tokyo Medical Center,Department of Urology
[9] University of Miyazaki,Department of Urology, Faculty of Medicine
[10] Kyoto Prefectural University of Medicine,Department of Biostatistics
[11] Foundation for Biomedical Research and Innovation at Kobe Translational Research Center for Medical Innovation,undefined
来源：
BMC Urology | / 22卷
关键词：
Combined androgen blockade; Enzalutamide; Non-metastatic castration-resistant prostate cancer; Progression-free survival; Radical treatment;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Apalutamide, enzalutamide, and darolutamide for non-metastatic castration-resistant prostate cancer: a systematic review and network meta-analysis
    Mori, Keiichiro
    Mostafaei, Hadi
    Pradere, Benjamin
    Motlagh, Reza Sari
    Quhal, Fahad
    Laukhtina, Ekaterina
    Schuettfort, Victor M.
    Abufaraj, Mohammad
    Karakiewicz, Pierre I.
    Kimura, Takahiro
    Egawa, Shin
    Shariat, Shahrokh F.
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2020, 25 (11) : 1892 - 1900
  • [22] Non-metastatic castration-resistant prostate cancer: current status and future directions
    Gupta, Ruby
    Sheng, Iris Y.
    Barata, Pedro C.
    Garcia, Jorge A.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2020, 20 (06) : 513 - 522
  • [23] Matching-Adjusted Indirect Comparison of the Efficacy of Apalutamide and Enzalutamide with ADT in the Treatment of Non-Metastatic Castration-Resistant Prostate Cancer
    Simon Chowdhury
    Stéphane Oudard
    Hiroji Uemura
    Steven Joniau
    Dominic Pilon
    Martin Ladouceur
    Ajay S. Behl
    Jinan Liu
    Lindsay Dearden
    Jan Sermon
    Suzy Van Sanden
    Joris Diels
    Boris A. Hadaschik
    Advances in Therapy, 2020, 37 : 501 - 511
  • [24] A European, prospective, observational study of enzalutamide in patients with metastatic castration-resistant prostate cancer: PREMISE
    Payne, Heather
    Robinson, Angus
    Rappe, Bernard
    Hilman, Serena
    De Giorgi, Ugo
    Joniau, Steven
    Bordonaro, Roberto
    Mallick, Stephane
    Dourthe, Louis-Marie
    Flores, Moises Mira
    Guma, Josep
    Baron, Benoit
    Duran, Aurea
    Pranzo, Alessandra
    Serikoff, Alexis
    Mott, David
    Herdman, Mike
    Pavesi, Marco
    De Santis, Maria
    INTERNATIONAL JOURNAL OF CANCER, 2022, 150 (05) : 837 - 846
  • [25] Assessment of Factors Predicting Disease Progression in Japanese Patients With Non-Metastatic Castration-resistant Prostate Cancer
    Miyake, Hideaki
    Watanabe, Kyohei
    Matsushita, Yuto
    Watanabe, Hiromitsu
    Tamura, Keita
    Motoyama, Daisuke
    Ito, Toshiki
    Sugiyama, Takayuki
    Otsuka, Atsushi
    ANTICANCER RESEARCH, 2020, 40 (02) : 1101 - 1106
  • [26] Consequences of an Early PSA Response to Enzalutamide Treatment for Japanese Patients with Metastatic Castration-resistant Prostate Cancer
    Kato, Haruo
    Furuya, Yosuke
    Miyazawa, Yoshiyuki
    Miyao, Takeshi
    Syuto, Takahiro
    Nomura, Masashi
    Sekine, Yoshitaka
    Koike, Hidekazu
    Matsui, Hiroshi
    Shibata, Yasuhiro
    Ito, Kazuto
    Suzuki, Kazuhiro
    ANTICANCER RESEARCH, 2016, 36 (11) : 6141 - 6149
  • [27] Epidemiology and natural history of non-metastatic castration-resistant prostate cancer in Russia
    Alekseev, B. Ya.
    Nyushko, K. M.
    Gafanov, R. A.
    Kirichek, A. A.
    Anzhiganova, Yu. V.
    Kopyltsov, E. I.
    Sundui, Yu. Yu.
    Pashanov, E. D.
    Petyushin, A. N.
    Matveev, V. B.
    ONKOUROLOGIYA, 2022, 18 (02): : 111 - 122
  • [28] Symptoms and Impacts in Non-Metastatic Castration-Resistant Prostate Cancer: Qualitative Study Findings
    Erin L. Tomaszewski
    Pierre Moise
    Robert N. Krupnick
    Jared Downing
    Margaret Meyer
    Shevani Naidoo
    Stefan Holmstrom
    The Patient - Patient-Centered Outcomes Research, 2017, 10 : 567 - 578
  • [29] Enzalutamide in Combination with Abiraterone Acetate in Bone Metastatic Castration-resistant Prostate Cancer Patients
    Efstathiou, Eleni
    Titus, Mark
    Wen, Sijin
    Troncoso, Patricia
    Hoang, Anh
    Corn, Paul
    Prokhorova, Ina
    Araujo, John
    Dmuchowski, Carl
    Melhem-Bertrandt, Amal
    Patil, Shiva
    Logothetis, Christopher J.
    EUROPEAN UROLOGY ONCOLOGY, 2020, 3 (01): : 119 - 127
  • [30] Next-generation androgen receptor inhibitors in non-metastatic castration-resistant prostate cancer
    Lavaud, Pernelle
    Dumont, Clement
    Thibault, Constance
    Albiges, Laurence
    Baciarello, Giulia
    Colomba, Emeline
    Flippot, Ronan
    Fuerea, Alina
    Loriot, Yohann
    Fizazi, Karim
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2020, 12
12345